On June 5, GlobeNewswire reported that the U.S.-listed pharmaceutical company Silo Pharma (Nasdaq: SILO) The board of directors has approved the purchase of bitcoin worth up to $1 million as a reserve asset. Silo Pharma CEO Eric Weisblum said the inclusion of Bitcoin in the company's reserves is a strategic decision that will diversify assets through a digital store of value and serve as a safeguard against inflation, a move that Silo Pharma expects will optimize long-term shareholder value.
The content is for reference only, not a solicitation or offer. No investment, tax, or legal advice provided. See Disclaimer for more risks disclosure.
The board of directors of the US pharmaceutical company Silo Pharma approved the purchase of 1 million dollars worth of Bitcoin as reserve assets.
On June 5, GlobeNewswire reported that the U.S.-listed pharmaceutical company Silo Pharma (Nasdaq: SILO) The board of directors has approved the purchase of bitcoin worth up to $1 million as a reserve asset. Silo Pharma CEO Eric Weisblum said the inclusion of Bitcoin in the company's reserves is a strategic decision that will diversify assets through a digital store of value and serve as a safeguard against inflation, a move that Silo Pharma expects will optimize long-term shareholder value.